Suppr超能文献

痴呆患者疼痛、精神病和激越之间的交互关系:一项整群随机临床试验的结果

The Interactive Relationship between Pain, Psychosis, and Agitation in People with Dementia: Results from a Cluster-Randomised Clinical Trial.

作者信息

Habiger Torstein F, Flo Elisabeth, Achterberg Wilco P, Husebo Bettina S

机构信息

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, University of Bergen, 5018 Bergen, Norway.

Department of Public Health and Primary Care, Leiden University Medical Center, 2300 RC Leiden, Netherlands.

出版信息

Behav Neurol. 2016;2016:7036415. doi: 10.1155/2016/7036415. Epub 2016 May 9.

Abstract

Background. Neuropsychiatric symptoms are common in people with dementia, and pain is thought to be an important underlying factor. Pain has previously been associated with agitation, and pain treatment has been shown to ameliorate agitated behaviour. So far, the association between pain and psychosis and the effect of pain treatment on psychotic symptoms is unclear. Furthermore, the impact of opioid treatment on psychosis is not established. Aim. To investigate the efficacy of a stepwise protocol for treating pain (SPTP) on psychosis and agitation measured with the Neuropsychiatric Inventory, Nursing Home version, and to explore the impact of opioid analgesics on psychosis. Method. Secondary analyses are from a cluster-randomised controlled trial including 352 patients with advanced dementia and agitation from 18 nursing homes in Western Norway. The intervention group received pain treatment according to SPTP. Results. Pain was associated with disinhibition (adjusted OR: 1.21, 95% CI: 1.10-1.34) and irritability (adjusted OR: 1.10, 95% CI: 1.01-1.21) at baseline. Pain treatment reduced agitation (p < 0.001, df = 1; 300) and aberrant motor behaviour (p = 0.017, df = 1; 300). Psychosis was reduced in people with at least one symptom at baseline (p = 0.034, df = 1; 135). The use of opioid analgesics did not increase psychotic symptoms. Study Registration. This trial is registered with ClinicalTrials.gov (NCT01021696), Norwegian Medicines Agency, EudraCT (EudraCTnr: 2008-007490-20).

摘要

背景。神经精神症状在痴呆患者中很常见,疼痛被认为是一个重要的潜在因素。疼痛此前一直与激越相关,并且疼痛治疗已被证明可改善激越行为。到目前为止,疼痛与精神病之间的关联以及疼痛治疗对精神病症状的影响尚不清楚。此外,阿片类药物治疗对精神病的影响尚未明确。目的。使用养老院版神经精神科问卷来研究疼痛阶梯治疗方案(SPTP)对精神病和激越的疗效,并探讨阿片类镇痛药对精神病的影响。方法。二次分析来自一项整群随机对照试验,该试验纳入了挪威西部18家养老院的352例晚期痴呆且伴有激越的患者。干预组根据SPTP接受疼痛治疗。结果。在基线时,疼痛与脱抑制(调整后的比值比:1.21,95%置信区间:1.10 - 1.34)和易激惹(调整后的比值比:1.10,95%置信区间:1.01 - 1.21)相关。疼痛治疗减轻了激越(p < 0.001,自由度 = 1;300)和异常运动行为(p = 0.017,自由度 = 1;300)。基线时至少有一项症状的患者的精神病症状有所减轻(p = 0.034,自由度 = 1;135)。使用阿片类镇痛药并未增加精神病症状。研究注册。该试验已在ClinicalTrials.gov(NCT01021696)、挪威药品管理局、欧盟临床试验数据库(EudraCT编号:2008 - 007490 - 20)注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f96b/4876223/b0109dbfd16a/BN2016-7036415.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验